Explore
Validate
Learn
Western blot
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-2382 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-2382, RRID:AB_10000854
- Product name
- Rabbit Polyclonal VEGFR2/KDR/Flk-1 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. This has only been shown to recognize the native form (180-190 kDa protein) of VEGFR-2, known as Flk-1/KDR/VEGFR 2 (Vascular Endothelial Growth Factor Receptor 2), though it was raised against the precursor form.
- Reactivity
- Human, Rat, Hamster
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 ml
- Concentration
- 1 mg/ml
- Storage
- Store at 4C. Do not freeze.
Submitted references Oral Mucosa Harbors a High Frequency of Endothelial Cells: A Novel Postnatal Cell Source for Angiogenic Regeneration.
Identification of autocrine growth factors secreted by CHO cells for applications in single-cell cloning media.
Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Zhou J, Rogers JH, Lee SH, Sun D, Yao H, Mao JJ, Kong KY
Stem cells and development 2017 Jan 15;26(2):91-101
Stem cells and development 2017 Jan 15;26(2):91-101
Identification of autocrine growth factors secreted by CHO cells for applications in single-cell cloning media.
Lim UM, Yap MG, Lim YP, Goh LT, Ng SK
Journal of proteome research 2013 Jul 5;12(7):3496-510
Journal of proteome research 2013 Jul 5;12(7):3496-510
Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.
Roan JN, Fang SY, Chang SW, Hsu CH, Huang CC, Chiou MH, Tsai YC, Lam CF
Journal of vascular surgery 2012 Nov;56(5):1381-9.e1
Journal of vascular surgery 2012 Nov;56(5):1381-9.e1
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Hu-Lowe DD, Zou HY, Grazzini ML, Hallin ME, Wickman GR, Amundson K, Chen JH, Rewolinski DA, Yamazaki S, Wu EY, McTigue MA, Murray BW, Kania RS, O'Connor P, Shalinsky DR, Bender SL
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 15;14(22):7272-83
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 15;14(22):7272-83
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: VEGF R2/KDR/Flk-1 Antibody [NB100-2382] - Detection of VEGFR2 doublet in CSF-IR/VEGFR2 chimera transfected lysate using NB100-2382. ECL 10 second exposure.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunocytochemistry/Immunofluorescence: VEGF R2/KDR/Flk-1 Antibody [NB100-2382] - VEGF R2/KDR/Flk-1 antibody was tested in Hela cells with DyLight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).
